Syed Hassaan Ali

Admin

Dr.

Profile

Join date: Jul 7, 2023

About

I am a lecturer at Department of Pharmaceutical Sciences (Prime Institute of Health Sciences, Islamabad) and dedicated medical writer with a strong academic background in pharmaceutical sciences and a deep interest in translating complex medical concepts into clear, engaging, and evidence-based content. My work focuses on bridging the gap between scientific research and public understanding by presenting accurate healthcare information in a concise and accessible manner.

With experience in academic writing, research analysis, and health communication, I specialize in creating well-structured articles on topics including pharmacognosy, pharmacology, therapeutics, disease management, and emerging trends in medicine. I am particularly passionate about promoting rational drug use, combating antimicrobial resistance, and highlighting the role of evidence-based medicine in improving patient outcomes.

As a contributor to Med-Report Foundation, I aim to deliver high-quality, reliable, and reader-friendly medical content that empowers individuals with knowledge and supports informed healthcare decisions.

Overview

First Name

Syed Hassaan

Last Name

Ali Shah

Posts (1)

May 19, 2026 ∙ 4 min

Is the Weight-Gain Era Over? 52-Week Data Confirms Cobenfy’s Long-Term Safety Profile in Schizophrenia treatment

Introduction Historically, the pharmacopeia for schizophrenia has been defined by dopaminergic blockade . Standard antipsychotics—both first and second-generation—rely on binding to postsynaptic D2 receptors , effectively "muting" overactive dopamine signaling in the mesolimbic pathway. 1,2 However, this "shotgun" binding profile isn't surgical. These agents often interact with a heterogeneous array of other targets: Serotonergic (5-HT): Often targeted to balance mood and motor side effects....